Clinical Trial - Assessment of Breast Cancer Margin
Filed with ASX · · 2 pages · English
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- Appendix 4E and 2018 Annual Report
- Market Update
- ZEISS CONVIVO and Appointment of Interim Executive Chairman
- Appendix 4D and Financial Statements - 31 Dec 2017
- Update on CEO Recruitment and Interim Management
Later from Optiscan Imaging
- Suspension from Official Quotation
- ZEISS achieves another milestone on regulatory pathway
- Reinstatement to Official Quotation
- OptiScan technology used in research at major cancer centre
- Collaboration Agreement with Summit Biomedical Imaging LLC
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging